Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH.
Circulation. 2009 Sep 8;120(10):835-42. Epub 2009 Aug 24.PMID: 19704100 [PubMed - indexed for MEDLINE]Related articles